Home / Health / Alzheimer's Gene Linked to Delirium: A Dual Brain Threat
Alzheimer's Gene Linked to Delirium: A Dual Brain Threat
25 Nov
Summary
- APOE4 gene, a known Alzheimer's risk, is now a risk for delirium.
- Each APOE4 copy increases delirium risk by 60%.
- Delirium can speed up mental decline, even in healthy individuals.
The APOE4 gene, a significant predictor of Alzheimer's disease, has now been identified as a distinct risk factor for delirium. This genetic link means individuals carrying APOE4 face a substantially increased vulnerability to delirium, with each copy raising the risk by about 60 percent. This finding challenges the perception of delirium as a mere symptom, revealing its potential to hasten cognitive decline, even in seemingly healthy adults.
The research indicates that the inflammation triggered by events like severe infection or surgery, which causes delirium, damages brain cells through a process similar to that seen in dementia. The APOE4 gene appears to make the brain uniquely susceptible to this inflammatory assault. This connection suggests a biological pathway where delirium can act as an early warning sign and actively contribute to long-term neurodegenerative damage.
By analyzing genetic and health data from over a million individuals, scientists pinpointed the APOE gene's crucial role. This breakthrough opens possibilities for developing targeted therapies designed to intercept the inflammatory process and mitigate the risk of delirium-induced cognitive impairment, offering hope for preventing irreversible mental decline.
